What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

被引：0
|
作者：
Muhammad Shahzeb Khan
Muthiah Vaduganathan
机构：
[1] Cook County Health and Hospital System,Department of Medicine
[2] Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School,Heart and Vascular Center
来源：
Current Diabetes Reports | 2020年 / 20卷
关键词：
Antihyperglycemic therapies; Diabetes mellitus; Heart failure; SGLT-2 inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Khan, Muhammad Shahzeb
    Vaduganathan, Muthiah
    [J]. CURRENT DIABETES REPORTS, 2020, 20 (11)
  • [2] The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
    Fadiran, Olusayo
    Nwabuo, Chike
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [3] Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure
    Chilton, Robert J.
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (05): : 1215 - 1218
  • [4] The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure
    Stachteas, Panagiotis
    Nasoufidou, Athina
    Patoulias, Dimitrios
    Karakasis, Paschalis
    Karagiannidis, Efstratios
    Mourtzos, Michail-Angelos
    Samaras, Athanasios
    Apostolidou, Xanthi
    Fragakis, Nikolaos
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [5] Sodium-glucose co-transporter-2 inhibitors in the treatment of diabetes with heart failure COMMENT
    Liang, Bo
    Gu, Ning
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [6] Eligibility of outpatients with chronic heart failure for sodium-glucose co-transporter-2 inhibitors
    Angelini, Gianmarco
    Albanese, Miriam
    Ursi, Raffaella
    Lisi, Francesco
    Bellino, Maria Consiglia
    Amato, Luca
    Gioia, Margherita Ilaria
    Parisi, Giuseppe
    Brunetti, Natale Daniele
    Piazzolla, Giuseppina
    Ciccone, Marco Matteo
    Iacoviello, Massimo
    [J]. ESC HEART FAILURE, 2021, 8 (04): : 2951 - 2958
  • [7] Sodium-glucose co-transporter-2 inhibitors as oral antidiabetic in patients wit heart failure
    Jose Morgado, J.
    Roa Garrido, J. R. G.
    Rodriguez Ortega, P. R. O.
    Martinez Mora, B. M. M.
    Camacho Freire, S. C. F.
    Moraleda Salas, T. M. S.
    Lopez Suarez, A. L. S.
    Diaz Fernandez, J. D. F.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 452 - 452
  • [8] Sodium-glucose co-transporter-2 inhibitors in the non-diabetic heart failure patient
    Essa, Hani
    Walker, Lauren
    Sankaranarayanan, Rajiv
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2566 - 2570
  • [9] Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischaemic heart disease
    Shen, Yun
    Zhou, Jian
    Shi, Lizheng
    Nauman, Elizabeth
    Katzmarzyk, Peter T.
    Price-Haywood, Eboni G.
    Horswell, Ronald
    Chu, San
    Yang, Shengping
    Bazzano, Alessandra N.
    Nigam, Somesh
    Hu, Gang
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (07): : 1197 - 1206
  • [10] Promise of sodium-glucose co-transporter-2 inhibitors in heart failure with mildly reduced ejection fraction
    Shen, Xizi
    Shen, Xingping
    [J]. ESC HEART FAILURE, 2022, 9 (04): : 2239 - 2248
12345